Translating molecular advances in Down syndrome and Fragile X syndrome into therapies
Ongoing treatments for genetic developmental disorders of the central nervous system are mostly symptomatic and do not correct the genetic cause. Recent identification of common mechanisms between diseases has suggested that new therapeutic targets could be applied across intellectual disabilities w...
主要な著者: | Faundez, V, De Toma, I, Bardoni, B, Bartesaghi, R, Nizetic, D, de la Torre, R, Kadosh, R, Herault, Y, Dierssen, M, Potier, M-C |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Elsevier
2018
|
類似資料
-
Modeling Fragile X Syndrome in Drosophila
著者:: Małgorzata Drozd, 等
出版事項: (2018-04-01) -
Fragile X Syndrome as an interneuronopathy: a lesson for future studies and treatments
著者:: Alessandra Tempio, 等
出版事項: (2023-04-01) -
Fragile X Mental Retardation Protein: To Be or Not to Be a Translational Enhancer
著者:: Thomas Maurin, 等
出版事項: (2018-12-01) -
A Male with Cooccurrence of Down Syndrome and Fragile X Syndrome
著者:: Tovi Anderson, 等
出版事項: (2013-01-01) -
The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?
著者:: Sara Castagnola, 等
出版事項: (2017-11-01)